ADMA Biologics, Inc.ADMANASDAQ
Loading
Asset Growth Recovery in ProgressRecovering
Percentile Rank72
3Y CAGR-15.1%
5Y CAGR+1.0%
Year-over-Year Change
Year-over-year total asset growth rate
3Y CAGR
-15.1%/yr
Quarterly compound
5Y CAGR
+1.0%/yr
Recent deceleration
Percentile
P72
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 9.77% |
| Q3 2025 | 1.85% |
| Q2 2025 | 9.36% |
| Q1 2025 | 4.48% |
| Q4 2024 | 25.10% |
| Q3 2024 | 3.78% |
| Q2 2024 | 7.27% |
| Q1 2024 | 6.59% |
| Q4 2023 | -5.68% |
| Q3 2023 | 1.74% |
| Q2 2023 | 0.66% |
| Q1 2023 | -2.20% |
| Q4 2022 | 15.94% |
| Q3 2022 | 1.22% |
| Q2 2022 | -3.60% |
| Q1 2022 | 11.50% |
| Q4 2021 | 15.76% |
| Q3 2021 | 2.50% |
| Q2 2021 | -1.21% |
| Q1 2021 | 13.48% |
| Q4 2020 | 9.32% |
| Q3 2020 | -0.82% |
| Q2 2020 | -9.02% |
| Q1 2020 | 65.65% |
| Q4 2019 | -7.76% |
| Q3 2019 | -3.83% |
| Q2 2019 | 83.40% |
| Q1 2019 | -12.10% |
| Q4 2018 | -16.43% |
| Q3 2018 | -9.69% |
| Q2 2018 | 29.20% |
| Q1 2018 | -15.63% |
| Q4 2017 | 48.35% |
| Q3 2017 | -13.97% |
| Q2 2017 | 381.04% |
| Q1 2017 | -25.71% |
| Q4 2016 | -13.86% |
| Q3 2016 | -13.38% |
| Q2 2016 | 61.25% |
| Q1 2016 | -16.99% |